British experts slam US for hoarding remdesivir
Ohid Yaqub, a senior lecturer at the University of Sussex called it “disappointing news” in a statement. “It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said.
- Country:
- United Kingdom
Some British experts have slammed the US decision to snap up nearly the entire global supply of remdesivir, the only drug licensed so far to treat COVID-19. Ohid Yaqub, a senior lecturer at the University of Sussex called it “disappointing news” in a statement.
“It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said. The U.S. government announced Tuesday that President Donald Trump had struck “an amazing deal” to buy the remdesivir drug for Americans, made by Gilead.
The Department of Health and Human Services said Trump has secured 500,000 treatments of the drug through September, representing 100 per cent of Gilead's July production capacity and 90 per cent of its capacity in August and September. In earlier stages of the pandemic, the U.S. refused to export pre-ordered masks to other countries, including Canada.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Prosecutors say they're open to delaying start of Donald Trump's March 25 hush-money trial
Prosecutors say they're open to delaying Donald Trump's March 25 hush-money trial for a month
FACTBOX-Donald Trump's tangled web of legal and financial worries
FACTBOX-Donald Trump's tangled web of legal and financial worries
FACTBOX-Donald Trump's tangled web of legal and financial worries